Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-18

Clinical Trial Update: Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps. [Phase 1, Phase 2]

View source ↗

Summary

A early-phase clinical trial investigating montelukast for chronic rhinosinusitis with nasal polyps (CRSwNP) is in Phase 1/Phase 2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast (Montelukast)

Snippet

Sponsor: Assiut University | Conditions: Montelukast, Chronic Rhinosinusitis With Nasal Polyps | Phase 1, Phase 2 | Status: UNKNOWN